A. Rachel Leheny, Director at Anthera Pharmaceuticals Inc (ANTH), bought 250,000 shares at $3.00 ($750K) on 2010-09-24, disclosed to the SEC on 2010-09-24.
Open-market purchase of $750k ANTH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CALC | BUY | 2024-11-01 | $75K | — | Filing → |
| CALC | BUY | 2024-08-27 | $4K | — | Filing → |
| CALC | BUY | 2023-11-08 | $7K | — | Filing → |